Ten Capital Wealth Advisors’s AstraZeneca AZN Stock Holding History

Ten Capital Wealth Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-356	Closed	-$49.4K	–	215
2023 Q1	$49.4K	Buy	356 +194	+120%	+$26.1K	0.02%	222
2022 Q4	$22K	Sell	162 -12	-7%	-$1.5K	0.01%	254
2022 Q3	$19K	Buy	174 +11	+7%	+$1.4K	0.01%	246
2022 Q2	$22K	Hold	163	–	–	0.01%	198
2022 Q1	$22K	Sell	163 -120	-42%	-$14.4K	0.01%	207
2021 Q4	$33K	Hold	283	–	–	0.01%	169
2021 Q3	$34K	Hold	283	–	–	0.02%	161
2021 Q2	$34K	Buy	283 +150	+113%	+$16.5K	0.01%	205
2021 Q1	$13K	Hold	133	–	–	﹤0.01%	245
2020 Q4	$13K	Buy	+133	New	+$14.1K	﹤0.01%	239

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ten Capital Wealth Advisors's AZN Position: Q2 2023 in Review

Ten Capital Wealth Advisors sold out of AstraZeneca (AZN) in Q2 2023, closing a stake of 356 shares — an estimated $49.4K sold.

Ten Capital Wealth Advisors first reported a position in AZN in Q4 2020 and held it in 10 quarters. The position peaked at $49.4K in Q1 2023. 1,092 funds tracked by Wall St. Rank hold AZN as of Q2 2023.

Ten Capital Wealth Advisors reported no remaining AstraZeneca position as of Q2 2023 after selling out during the quarter.
Ten Capital Wealth Advisors sold 356 AstraZeneca shares in Q2 2023, an estimated $49.4K.
Ten Capital Wealth Advisors first reported a position in AstraZeneca in Q4 2020 and held it in 10 quarters.
Ten Capital Wealth Advisors's AstraZeneca position peaked at $49.4K in Q1 2023.
1,092 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2023.

Based on Ten Capital Wealth Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.